Cheesman, Rosa http://orcid.org/0000-0002-6543-0402
Eilertsen, Espen Moen
Ahmadzadeh, Yasmin I.
Gjerde, Line C.
Hannigan, Laurie J.
Havdahl, Alexandra
Young, Alexander I.
Eley, Thalia C.
Njølstad, Pål R.
Magnus, Per
Andreassen, Ole A.
Ystrom, Eivind
McAdams, Tom A.
Funding for this research was provided by:
Norwegian Research Council (262177, 288083, 229624, 223273, 240413/F20, 223273, 248778, 273291)
UK Medical Research Council (MR/M021475/1)
South-Eastern Norway Regional Health Authority (2018058, 2018059)
Henry Dale Fellowship (107706/Z/15/Z)
ERC (293574)
Novo Nordisk Foundation (54741)
Helse Vest (911745)
Horizon 2020 (847776)
Article History
Received: 30 April 2020
Accepted: 24 August 2020
First Online: 27 October 2020
Ethics approval and consent to participate
: Written informed consent was obtained from all participants upon recruitment. The establishment and data collection in MoBa was previously based on a licence from the Norwegian Data Protection Agency and approval from The Regional Committee for Medical Research Ethics, and it is now based on regulations related to the Norwegian Health Registry Act. The current study was approved by The Regional Committee for Medical Research Ethics.
: OAA received speaker’s honorarium from Lundbeck and is a consultant to HealthLytix.